Premium Research
Peptides

GUT Blend – Capsules (60 Count) BPC-157 (500 mcg) / KPV (500 mcg) / GHK-Cu (1 mg) / PEA (50 mcg) This combination (BPC-157, KPV, GHK-Cu, PEA) is a high-potency research peptide stack designed for comprehensive tissue regeneration, intensive inflammation control, and immune system modulation. By combining these specific agents, the formula addresses both structural repair (muscles, tendons) and chemical/immune-based inflammation.

GW501516 – 10 mg Capsules (60 Count) GW501516 (Cardarine) 10 mg capsules (60 count) are often marketed as a supplement for boosting endurance, fat loss, and muscle growth by acting as a PPARδ agonist. Originally developed for metabolic diseases, it was abandoned in clinical trials due to causing cancer in animal studies. It is not approved for human consumption.

Metformin – 500 mg Capsules (60 Count) Metformin 500 mg tablets are a common, first-line oral medication used to manage blood sugar levels in adults with type 2 diabetes, often as an adjunct to diet and exercise. It increases insulin sensitivity and reduces glucose production in the liver. Typical dosing starts at 500 mg twice daily, taken with meals to minimize gastrointestinal side effects.

MK-677 – 12.5 mg Capsules (60 Count) MK-677 (Ibutamoren) 12.5 mg capsules are used in research settings to stimulate growth hormone (GH) and insulin-like growth factor 1 (IGF-1) levels by mimicking the ghrelin hormone. Often used for potential benefits in muscle growth, fat loss, and improved sleep, it is not approved by the FDA for human consumption.

RAD-140 – 10 mg Capsules (60 Count) RAD-140 (Testolone) is an experimental selective androgen receptor modulator (SARM) not approved for human use, despite being sold as a 10 mg bodybuilding supplement for muscle growth and fat loss. It is linked to severe,, acute liver injury (hepatotoxicity), cardiac issues like myopericarditis, and is a banned substance by Sport Integrity Australia.

Reduce Blend – Capsules (60 Count) SLU-PP-332 (250 mcg) / BAM15 (50 mg) SLU-PP-332 (250 mcg) and BAM15 are experimental compounds studied for metabolic health and obesity management. SLU-PP-332 functions as an ERR agonist that acts as an exercise mimetic, enhancing fatty acid oxidation and mitochondrial function. BAM15 is a mitochondrial uncoupler that increases energy expenditure and improves glycemic control.